Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' TSAVARIS N' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 60 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kosmas, C; Tsavaris, N; Panopoulos, C; Vadiaka, M; Stavroyianni, N; Kourelis, T; Malamos, N; Antonopoulos, M; Kalofonos, HP
      Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane plus platinum-based regimens

      EUROPEAN JOURNAL OF CANCER
    2. Kakolyris, S; Mavroudis, D; Tsavaris, N; Souglakos, J; Tsiafaki, P; Kalbakis, K; Agelaki, S; Androulakis, N; Georgoulias, V
      Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study

      ANNALS OF ONCOLOGY
    3. Stathopoulos, GP; Mavroudis, D; Tsavaris, N; Kouroussis, C; Aravantinos, G; Agelaki, S; Kakolyris, S; Rigatos, SK; Karabekios, S; Georgoulias, V
      Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: A phase II study of the Greek Cooperative Group for Pancreatic Cancer

      ANNALS OF ONCOLOGY
    4. Tsavaris, N; Kosmas, C; Vadiaka, M; Kontos, A; Katsorida, M; Dimitrakopoulos, A; Zerai, A; Koufos, C
      Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    5. Polyzos, A; Tsavaris, N; Kosmas, C; Arnaouti, T; Kalahanis, N; Tsigris, C; Giannopoulos, A; Karatzas, G; Giannikos, L; Sfikakis, PP
      Hypersensitivity reactions to carboplatin administration are common but not always severe: A 10-year experience

      ONCOLOGY
    6. Kosmas, C; Tsavaris, N; Vadiaka, M; Stavroyianni, N; Koutras, A; Malamos, N; Onyenadum, A; Rokana, S; Polyzos, A; Kalofonos, HP
      Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens

      CANCER
    7. Polyzos, A; Kosmas, C; Tsavaris, N; Markopoulos, C; Kalahanis, N; Papadopoulos, O; Arnaouti, T; Sfikakis, PP
      Doxorubicin plus ifosfamide as salvage treatment for patients with advanced breast cancer refractory to epirubicin plus cyclophosphamide

      CLINICAL DRUG INVESTIGATION
    8. Tsavaris, N; Skarlos, D; Bacoyiannis, C; Aravantinos, G; Kosmas, C; Retalis, G; Panopoulos, C; Vadiaka, M; Dimitrakopoulos, A; Kostantinidis, K; Mitropoulos, D; Bougas, D; Pantazopoulos, D; Kosmidis, P
      Combined treatment with low-dose interferon plus vinblastine is associatedwith less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    9. Mavroudis, D; Alexopoulos, A; Ziras, N; Malamos, N; Kouroussis, C; Kakolyris, S; Agelaki, S; Kalbakis, K; Tsavaris, N; Potamianou, A; Rigatos, G; Georgoulias, V
      Front-line treatment of advanced breast cancer with docetaxel and epirubicin: A multicenter phase II study

      ANNALS OF ONCOLOGY
    10. Tsavaris, N; Kosmas, C; Mylonakis, N; Bacoyiannis, C; Kalergis, G; Vadiaka, M; Boulamatsis, D; Iakovidis, V; Kosmidis, P
      Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy

      ANTICANCER RESEARCH
    11. Kosmas, C; Malamos, NA; Tsavaris, N; Antonopoulos, M
      Chemotherapy-induced complete regression of choroidal metastases and subsequent isolated leptomeningeal carcinomatosis in advanced breast cancer: a case report and literature review

      JOURNAL OF NEURO-ONCOLOGY
    12. Tsavaris, N; Kosmas, C; Vadiaka, W; Kanelopoulos, P; Kontos, A; Katsorida, M; Agelopoulou, A; Vrizidis, N; Fotia, M; Papoutsis, K; Koufos, C
      Ondansentron and dexamethasone treatment with different dosing schedules (24 versus 32 mg) in patients with non-small-cell lung cancer under cisplatin-based chemotherapy: A randomized study

      CHEMOTHERAPY
    13. Polyzos, A; Tsavaris, N; Kosmas, C; Petrikos, G; Stamatiadis, D; Kalahanis, N; Giannopoulos, A; Karatzas, G; Sfikakis, PP
      Double biochemical modulation of 5-fluorouracil by methotrexate and folinic acid for the treatment of advanced colorectal cancer

      CLINICAL DRUG INVESTIGATION
    14. Polyzos, A; Tsavaris, N; Kosmas, C; Petrikos, G; Giannikos, L; Kalahanis, N; Papadopoulos, O; Christodoulou, K; Giannakopoulos, K; Veslemes, M; Katsilambros, N
      Second-line chemotherapy with cisplatin-ifosfamide in patients with ovarian cancer previously treated with carboplatin-cyclophosphamide

      JOURNAL OF CHEMOTHERAPY
    15. Sipsas, NV; Aroni, K; Tsavaris, N; Mavragani, K; Paikos, S; Kordossis, T
      AIDS-related cutaneous Kaposi's sarcoma: Failure of treatment with human chorionic gonadotropin

      JOURNAL OF CHEMOTHERAPY
    16. Androulakis, N; Kourousis, C; Dimopoulos, MA; Samelis, G; Kakolyris, S; Tsavaris, N; Genatas, K; Aravantinos, G; Papadimitriou, C; Karabekios, S; Stathopoulos, GP; Georgoulias, V
      Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: A multicenter phase II study

      JOURNAL OF CLINICAL ONCOLOGY
    17. Polyzos, A; Tsavaris, N; Kosmas, C; Giannikos, L; Katsikas, M; Kalahanis, N; Karatzas, G; Christodoulou, K; Giannakopoulos, K; Stamatiadis, D; Katsilambros, N
      A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer

      ONCOLOGY
    18. TSAVARIS N; TENTAS K; TZIVRAS M; KOSMAS C; KALACHANIS N; KATSIKAS M; DIMITRAKOPOULOS A; PAPASTRATIS G; MACHERAS A; KARATZAS G; SECHAS M
      COMBINED EPIRUBICIN, 5-FLUOROURACIL AND FOLINIC ACID VS NO TREATMENT FOR PATIENTS WITH ADVANCED PANCREATIC-CANCER - A PROSPECTIVE COMPARATIVE-STUDY

      Journal of chemotherapy
    19. TSAVARIS N; MYLONAKIS N; BACOYIANNIS C; KOSMAS C; KALERGIS G; IAKOVIDIS V; TZANINIS D; KOSMIDIS P
      FACTORS THAT INFLUENCE THE ANTIEMETIC ACTIVITY OF METOCLOPRAMIDE TO CISPLATIN-BASED CHEMOTHERAPY

      Oncology Reports
    20. TSAVARIS N; BAXEVANIS CN; KOSMAS C; PAPALAMBROS E; PAPAMICHAEL M
      IMMUNE CHANGES IN PATIENTS (PTS) WITH COLON-CANCER (CC) TREATED WITH ADJUVANT THERAPY WITH 17-1A MONOCLONAL-ANTIBODY (MOAB)

      Annals of oncology
    21. ANDROULAKIS N; KOUROUSIS C; DIMOPOULOS AM; SAMELIS G; TSAVARIS N; GENATAS K; PANAGOS G; ARAVANTINOS G; STATHOPOULOS G; GEORGOULIAS V
      TREATMENT OF PANCREATIC-CANCER WITH DOCETAXEL AND GRANULOCYTE-COLONY-STIMULATING FACTOR - A MULTICENTER PHASE-II STUDY

      Annals of oncology
    22. POLYZOS A; TSAVARIS N; KOSMAS C; ARNAOUTIS T; APOSTOLOPOULOS P; VAFIADIS I; TSATALI K; TOSKAS A; NIKOU G
      GEMCITABINE(GEM) PLUS B-FLUOROURACIL (5-FU) BY MODULATED BY LEUCOVORIN (LV) FOR ADVANCED PANCREATIC-CANCER)

      Annals of oncology
    23. KOSMAS C; TSAVARIS N; POLYZOS A; SEPSAS E; MALAMOS N; KALOFONOS HP; PANOPOULOS C; ANTONOPOULOS MJ
      PACLITAXEL (TAXOL)-IFOSFAMIDE-CISPLATIN (TIP) CHEMOTHERAPY (CMT) REGIMEN IN PATIENTS (PTS) WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY

      Annals of oncology
    24. Koufos, C; Tsavaris, N; Travlou, A
      Unusual development of an abdominal neoplasm in a patient with Maffucci's syndrome

      PANMINERVA MEDICA
    25. TSAVARIS N; FOUNTZILAS G; MYLONAKIS N; ATHANASSIADIS A; KOSMAS C; KARAKOUSIS C; BACOYIANNIS C; KOSMIDIS P
      A RANDOMIZED COMPARATIVE-STUDY OF ANTIEMETIC PROPHYLAXIS WITH ONDANSENTRON IN A SINGLE 32-MG LOADING DOSE VERSUS 8 MG EVERY 6 H IN PATIENTSUNDERGOING CISPLATIN-BASED CHEMOTHERAPY

      Oncology
    26. BRIASOULIS E; TSAVARIS N; FOUNTZILAS G; ATHANASIADIS A; KOSMIDIS P; BAFALOUKOS D; SAMANTAS E; PAVLIDIS N
      COMBINATION REGIMEN WITH CARBOPLATIN, EPIRUBICIN AND ETOPOSIDE IN METASTATIC CARCINOMAS OF UNKNOWN PRIMARY SITE - A HELLENIC COOPERATIVE ONCOLOGY GROUP PHASE-II STUDY

      Oncology
    27. POLYZOS A; TSAVARIS N; VESLEMES M; DARDOUFAS K; DOSIOS T; KOSMAS C
      CHEMOTHERAPY OF NON-SMALL-CELL LUNG-CANCER - A PROSPECTIVELY RANDOMIZED STUDY OF CISPLATIN-ETOPOSIDE VERSUS CISPLATIN-MITOMYCIN-VINBLASTINE

      Journal of chemotherapy
    28. POLYZOS A; TSAVARIS N; GIANNIKOS L; KALAHANIS N; CHRISTODOULOU K; GIANNAKOPOULOS K; NIKOU G; TOSKAS A; PAPARGYRIOU J; KATSILAMBROS N
      PACLITAXEL (PX) CARBOPLATIN (CBP) VERSUS CYCLOPHOSPHAMIDE (CTX)-CARBOPLATIN SUPPORTED BY G-CSF AS FIRST LINE CHEMOTHERAPY IN FIGO III-IV OVARIAN-CARCINOMA (OC)

      European journal of cancer
    29. GENNATAS CS; PSYCHOGIOS J; DARDOUFAS C; TSAVARIS N; ATHANASIADIS S
      4-HYDROXYANDROSTENEDIONE (4-OHA) AS 3RD-LINE ENDOCRINE THERAPY IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER

      European journal of cancer
    30. KOSMAS C; TSAVARIS N; POLYZOS A
      PHASE I II STUDY OF TAXOL/IFOSFAMIDE/CISPLATIN (TIP) COMBINATION CHEMOTHERAPY (CMT) IN ADVANCED SOLID TUMORS (ST)/

      European journal of cancer
    31. TSAVARIS N; KOSMIDIS P; KOSMAS C; KATSIKAS M; BACOYIANNIS C; MYLONAKIS N; PAPALAMBROS E; KOUFOS C; BASTOUNIS E; SECHAS M
      CONTRIBUTION OF CHEMOTHERAPY (CMT) TO THE SURVIVAL(S) OF PATIENTS(P) WITH ADVANCED GASTRIC-CANCER (AGC) - A RETROSPECTIVE COMPARATIVE-STUDYOF PATIENTS WHO RECEIVED AND THOSE WHO REFUSED TREATMENT (TX)

      European journal of cancer
    32. KOSMIDIS PA; BACOYIANNIS C; FOUNTZILAS G; ARAVANTINOS G; TSAVARIS N; MILATHIANAKIS C; SKARLOS D
      5-FLUOROURACIL, INTERFERON-ALPHA-2B AND CISPLATIN (FAP) FOR ADVANCED UROTHELIAL CANCER - A PHASE-II STUDY

      Annals of oncology
    33. ATHANASSIOU A; VARTHALITIS J; TSAVARIS N; DIMITRIDIS M; MOUTZOURIDIS G
      SUPERIORITY OF CARBOPLATIN MONOCHEMOTHERAPY OVER CARBOPLATIN-BASED POLYCHEMOTHERAPY IN OVARIAN-CANCER

      European journal of gynaecological oncology
    34. TSAVARIS N; POLYZOS A; KOSMAS C; GIANNIKOS L; GOGAS J
      A FEASIBILITY STUDY OF 1-H PACLITAXEL INFUSION IN PATIENTS WITH SOLIDTUMORS

      Cancer chemotherapy and pharmacology
    35. TSAVARIS N; PRIMIKIRIOS N; MYLONAKIS N; VAROUCHAKIS G; DOSIOS T; PAVLIDIS N; SKARLOS D; TASOPOULOS T; DRITSAS J; KOSMIDIS P
      COMBINATION CHEMOTHERAPY WITH CISPLATIN AND OR DOXORUBICIN IN MALIGNANT MESOTHELIOMA - A PROSPECTIVE-STUDY/

      Anticancer research
    36. KOSMIDIS PA; TSAVARIS N; SKARLOS D; THEOCHARIS D; SAMANTAS E; PAVLIDIS N; BRIASSOULIS E; FOUNTZILAS G
      FLUOROURACIL AND LEUCOVORIN WITH OR WITHOUT INTERFERON ALFA-2B IN ADVANCED COLORECTAL-CANCER - ANALYSIS OF A PROSPECTIVE RANDOMIZED PHASE-III TRIAL

      Journal of clinical oncology
    37. POLYZOS A; TSAVARIS N; GIANNOPOULOS A; BACOYIANNIS C; PAPADIMAS V; KALAHANIS N; KARATZAS G; KOSMAS C; SAKELAROPOULOS N; ARCHIMANDRITIS A; PAPACHRISTODOULOU A; KOSMIDIS P
      BIOCHEMICAL MODULATION OF FLUOROURACIL - COMPARISON OF METHOTREXATE, FOLINIC ACID, AND FLUOROURACIL VERSUS FOLINIC ACID AND FLUOROURACIL INADVANCED COLORECTAL-CANCER - A RANDOMIZED TRIAL

      Cancer chemotherapy and pharmacology
    38. TSAVARIS N; BAXEVANIS C; KOSMIDIS P; PAPAMICHAEL M
      THE PROGNOSTIC-SIGNIFICANCE OF IMMUNE CHANGES IN PATIENTS WITH RENAL-CANCER, MELANOMA AND COLORECTAL-CANCER, TREATED WITH INTERFERON-ALPHA-2B

      Cancer immunology and immunotherapy
    39. BAFALOUKOS D; PAVLIDIS N; FOUNTZILAS G; SKARLOS D; KLOUVAS G; MAKRANTONAKIS P; GIANNAKAKIS T; TSAVARIS N; KOSMIDIS P
      RECOMBINANT INTERFERON ALFA-2A IN COMBINATION WITH CARBOPLATIN, VINBLASTINE, AND BLEOMYCIN IN THE TREATMENT OF ADVANCED MALIGNANT-MELANOMA

      American journal of clinical oncology
    40. KOSMOPOULOU O; FOUKANELI T; TSAVARIS N; AGAPITOS E; SERETIS A; KORDOSSIS T
      LUNG SQUAMOUS-CELL CARCINOMA PRESENTING WITH BRAIN METASTASES IN AN HIV-POSITIVE PATIENT

      Lung cancer
    41. PATERAKIS GS; TSAVARIS N; LOUKOPOULOS D
      THE EFFECT OF GM-CSF ON RETICULOCYTES, HEMOGLOBIN AND HEMATOCRIT IN PATIENTS RECEIVING CHEMOTHERAPY FOR SOLID TUMORS

      Clinical and laboratory haematology
    42. FOUNTZILAS G; KATSOHIS K; TOUSSIS D; KOSMIDIS P; SEMOGLOU C; FAHANTIDIS E; TSAVARIS N; MAKRANTONAKIS P; ZAMBOGLOU N; HAINOGLOU D; PAVLIDIS N; POLICHRONIS A; GENNATAS K; SKARLOS D; VASSILAROS S; GIANNAKAKIS T; KLOUVAS G; KONSTANTARAS C; KOLOTAS C; TSILIAKOS S; MYLONAKIS N
      CYCLOPHOSPHAMIDE, MITOXANTRONE, FLUOROURACIL VERSUS CONVENTIONAL CMF AS ADJUVANT TREATMENT IN NODE-POSITIVE BREAST-CANCER PATIENTS - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY

      Oncology
    43. TSAVARIS N; TENTAS K; KOSMIDIS P; MYLONAKIS N; SAKELAROPOULOS N; KOSMAS C; LISAIOS B; SOUMILAS A; MANDREKAS D; TSETIS A; KLONARIS C
      A RANDOMIZED TRIAL COMPARING ADJUVANT FLUOROURACIL, EPIRUBICIN, AND MITOMYCIN WITH NO TREATMENT IN OPERABLE GASTRIC-CANCER

      Chemotherapy
    44. TSAVARIS N; MYLONAKIS N; BACOYIANNIS C; KARVOUNIS N; KORDOSSIS T; DALIANI D; KARABELIS A; KOSMIDIS P
      USE OF NAPROXEN IN AMELIORATING INDUCED PARANEOPLASTIC FEVER

      Clinical drug investigation
    45. TSAVARIS N; FOUTZILAS G; MARKANTONAKIS P; MYLONAKIS N; BACOYANNIS C; ZISIADIS A; BASDANIS G; KARVOUNIS N; SOBOLOS K; KOSMIDIS P
      A COMPARATIVE-STUDY WITH 2 ADMINISTRATION SCHEDULES OF LEUCOVORIN AND5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER

      Journal of chemotherapy
    46. TSAVARIS N; BAXEVANIS K; KOSMIDIS P; PAPAMICHAEL M
      THE PROGNOSTIC-SIGNIFICANCE OF IMMUNE CHANGES IN PATIENTS WITH RENAL-CANCER AND MELANOMA TREATED WITH INTERFERON-ALPHA(2B)

      Tumor biology
    47. TSAVARIS N; TENTAS K; BACOYIANNIS C; KATSIKAS M; SAKELAROPOULOS N; KOSMAS C; DALIANI D; KOSMIDIS P
      5-FLUOROURACIL, FOLINIC ACID AND CISPLATIN IN ADVANCED COLORECTAL-CANCER - A PILOT-STUDY

      Anti-cancer drugs
    48. TSAVARIS N; MYLONAKIS N; BACOYIANNIS C; PAPASTRATIS G; KATSIKAS M; PAPADIMITRAKOPOULOU V; MACHERAS A; STAMELOU A; KOSMIDIS P
      COMBINED EPIRUBICIN, EPIRUBICIN, 5-FLUOROURACIL AND FOLINIC ACID WITHALLOPURINOL PROTECTION FOR 2ND-LINE TREATMENT OF ADVANCED GASTRIC-CANCER - A PILOT-STUDY

      Onkologie
    49. TSAVARIS N; CHARALAMBIDIS G; GANAS N; PAGOU M; KARABELLIS A; MYLONAKIS N; BENOU N; TSIKALAKIS D; KOSMIDIS P
      ONDANSETRON VERSUS METOCLOPRAMIDE AS ANTIEMETIC TREATMENT DURING CISPLATIN-BASED CHEMOTHERAPY - A PROSPECTIVE-STUDY WITH SPECIAL REGARD TO ELECTROLYTE IMBALANCE

      Acta oncologica
    50. TSAVARIS N; MYLONAKIS N; BACOYIANNIS C; KARVOUNIS N; CHARALAMBIDIS G; PAGOU M; LIONI A; DALIANI D; KOSMIDIS P
      EFFICACY OF ONDANSETRON TREATMENT WITH DIFFERENT TIMING SCHEDULES - ARANDOMIZED DOUBLE-BLIND-STUDY

      Oncology
    51. TSAVARIS N; KONSTANTOPOULOS K; VAIDAKIS S; KOUMAKIS K; PANGALIS G
      CYTOCHEMICAL DETERMINATION OF MONOAMINE-OXIDASE ACTIVITY IN LYMPHOCYTES AND NEUTROPHILS OF SCHIZOPHRENIC-PATIENTS

      Haematologia
    52. TSAVARIS N; GOGOU L; TZANINIS D; TZIVRAS M; KOURAKLIS G; KOUTSIOUBAKAZAKOU P; KOSMIDIS P; ARCHIMANDRITIS A
      COMPARISON OF TUMOR-MARKERS CEA, ALPHA-FETOPROTEIN, CA-125, CA-19.9, CA-72.4 AND CA-50 IN PATIENTS WITH ADVANCED GASTRIC-CANCER

      Diagnostic oncology
    53. TSAVARIS N; MYLONAKIS N; BACOYIANNIS C; KATSIKAS M; LIONI A; KOSMIDIS P
      COMPARISON OF ONDANSENTRON VERSUS ONDANSENTRON PLUS METHYLPREDNISOLONE AS ANTIEMETIC PROPHYLAXIS DURING CISPLATIN-CONTAINING CHEMOTHERAPY

      Journal of pain and symptom management
    54. TSAVARIS N; BACOYIANNIS C; MYLONAKIS N; KARVOUNIS N; ZINELIS A; TSOUTSOS E; KOSMIDIS P
      AN ALTERNATIVE SCHEDULE BASED ON IFOSFAMIDE (IFM) IN COMBINATION WITHDOXORUBICIN (ADM), VINCRISTIN (VCR) AND ACTINOMYCIN-D (ACTD) IN ADVANCED SOFT-TISSUE SARCOMAS (STS) OF ADULTS - A PILOT-STUDY

      Journal of experimental & clinical cancer research
    55. TSAVARIS N; CHARALAMBIDIS G; PAGOU M; KARABELIS A; MYLONAKIS N; BACOYIANNIS C; KOSMIDIS P
      COMPARISON OF ONDANSENTRON (GR 3X032F) VERSUS ONDANSENTRON PLUS ALPRAZOLAM AS ANTIEMETIC PROPHYLAXIS DURING CISPLATIN-CONTAINING CHEMOTHERAPY

      American journal of clinical oncology
    56. KORDOSSIS T; KOSMOPOULOU O; ZAGOREOS J; DOSSIOS T; DELADETSIMA I; TSAVARIS N; SIPSAS N; STRATIGOS J; PAPAVASSILIOU K
      MALIGNANT MESOTHELIOMA IN AN HIV-POSITIVE PATIENT

      AIDS
    57. TSAVARIS N; MYLONAKIS N; KARVOUNIS N; BACOYIANNIS C; BRIASOULIS E; SKARLOS D; PAVLIDIS N; STAMATELOS G; KOSMIDIS P
      COMBINATION CHEMOTHERAPY WITH CISPLATIN-VINBLASTINE IN MALIGNANT MESOTHELIOMA

      Lung cancer
    58. ARCHIMANDRITIS A; BITSIKAS J; TJIVRAS M; ANASTASAKOU E; TSAVARIS N; KALOGERAS D; DAVARIS P; FERTAKIS A
      NON-CARDIA GASTRIC ADENOCARCINOMA AND HELICOBACTER-PYLORI INFECTION

      The Italian Journal of Gastroenterology
    59. ARCHIMANDRITIS A; BITSIKAS J; TJIVRAS M; ANASTASAKOU E; TSAVARIS N; KALOGERAS D; DAVARIS P; FERTAKIS A
      NONCARDIAC GASTRIC ADENOCARCINOMA AND HELICOBACTER-PYLORI INFECTION

      Gastroenterology
    60. TSAVARIS N; MYLONAKIS N; BACOYIANNIS C; TSOUTSOS H; KARABELIS A; KOSMIDIS P
      TREATMENT OF RENAL-CELL CARCINOMA WITH ESCALATING DOSES OF ALPHA-INTERFERON

      Chemotherapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 08:32:04